COMPARISON OF THE CLINICAL ACTIVITY OF TWO OXAZOLIDINONES – LINEZOLID AND TEDIZOLIDE: UNJUSTIFIED EXPECTATIONS

COMPARISON OF THE CLINICAL ACTIVITY OF TWO OXAZOLIDINONES – LINEZOLID AND TEDIZOLIDE: UNJUSTIFIED EXPECTATIONS

Skin and soft tissue infections are one of the most common nosocomial infections, which are caused most often by gram-positive bacteria (staphylococci, streptococci, enterococci) with multiple drug resistance. These infections are among the major nosocomial infections in oncology clinics along with...

Full description

Bibliographic Details
Main Authors:	N. V. Dmitrieva, I. N. Petuhova, Z. V. Grigorievskaya, N. S. Bagirova, I. V. Tereshchenko
Format:	Article
Language:	Russian
Published:	Tomsk National Research Medical Center of the Russian Academy of Sciences 2018-11-01
Series:	Sibirskij Onkologičeskij Žurnal
Subjects:	linezolid tedizolide comparison of linezolid and tedizolide skin and soft tissue infections cancer patients vancomycin-resistant streptococcus faecalis methicillin-resistant staphylococcus aureus
Online Access:	https://www.siboncoj.ru/jour/article/view/863

Similar Items

New and old oxazolidinones: tedizolid vs. linezolid
by: Dekhnich A.V., et al.
Published: (2017-05-01)

Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
by: Ferrández O, et al.
Published: (2016-12-01)

Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials
by: Gregory J. Moran, et al.
Published: (2018-09-01)

Global Expansion of Linezolid-Resistant Coagulase-Negative Staphylococci
by: Vladimir Gostev, et al.
Published: (2021-09-01)

Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis
by: Shao-Huan Lan, et al.
Published: (2019-09-01)

Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China
by: Shu’an Wen, et al.
Published: (2021-08-01)

Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
by: Alicia Rodríguez-Gascón, et al.
Published: (2021-06-01)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
by: Dana Binyamin, et al.
Published: (2018-06-01)

In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey
by: Alicem Tekin, et al.
Published: (2014-09-01)

Use of Linezolid in the treatment of surgical infectious complications under antibiotic resistance
by: O A Nazarchuk, et al.
Published: (2021-03-01)

Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity
by: Magdalena Paczkowska-Walendowska, et al.
Published: (2021-12-01)

Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
by: Afzal Husain, et al.
Published: (2018-04-01)

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
by: Anna Gidari, et al.
Published: (2020-08-01)

Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus
by: Hideo Kato, et al.
Published: (2021-03-01)

Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs
by: Eva Benavent, et al.
Published: (2021-01-01)

Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
by: Olufemi Emmanuel Babalola
Published: (2020-12-01)

Risk factors and outcome associated with the acquisition of linezolid-resistant Enterococcus faecalis
by: Eduardo Rodríguez-Noriega, et al.
Published: (2020-06-01)

In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
by: Weifeng Yang, et al.
Published: (2018-05-01)

Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption
by: Flaminia Olearo, et al.
Published: (2021-02-01)

Recurrent linezolid-resistant Enterococcus faecalis infection in a patient with pneumonia
by: Zhi-jian Yu, et al.
Published: (2015-01-01)

Tedizolid – a new antibiotic to solve old problems: prospects for the treatment of complicated skin and soft tissue infections
by: A. V. Rodin, et al.
Published: (2019-04-01)

Investigation of the Minimal Inhibitory Concentration Values of Vancomycin, Teicoplanin and Linezolid among MRSA Isolated from Inpatients by E-test Method
by: Tuğrul HOŞBUL, et al.
Published: (2012-06-01)

Complications of MRSA Treatment: Linezolid-induced Myelosuppression Presenting with Pancytopenia
by: Gorchynski, Julie A, et al.
Published: (2008-08-01)

Emergence de la résistance au linézolide chez les staphylocoques
by: Rouard, Caroline
Published: (2018)

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
by: Laia Fernández-Barat, et al.
Published: (2019-07-01)

First description of clinical linezolid resistant Enterococcus sp. in North Africa
by: A. Raddaoui, et al.
Published: (2020-06-01)

Potential of the Introduction of Tedizolid for the Treatment of Complicated Skin and Soft Tissue Infections in a Russian Multi-Field Hospital
by: Belkova Yu.А., et al.
Published: (2016-08-01)

Uso de linezolid para el tratamiento de recién nacidos con infecciones por Enterococcus faecium resistentes a la vancomicina Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium
by: G. Berberian, et al.
Published: (2009-03-01)

In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
by: Siheng Wang, et al.
Published: (2021-08-01)

In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India
by: Sheetal Chitnis, et al.
Published: (2013-01-01)

Quantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: A systematic review
by: Chang-Ro eLee, et al.
Published: (2015-08-01)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
by: Timothy David Shaw, et al.
Published: (2021-08-01)

Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature Endocarditis por Enterococcus raffinosus resistente a vancomicina exitosamente tratada con linezolid: caso clínico y revisión de la literatura
by: A. Jasovich, et al.
Published: (2008-12-01)

Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
by: Qi C, et al.
Published: (2019-11-01)

Isolated reversible toxic optic neuropathy secondary to linezolid
by: Liron Berkovitz, et al.
Published: (2017-01-01)

Evolution of Multi-Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus Causing Persistent Bacteremia
by: Chih-Jung Chen, et al.
Published: (2020-07-01)

ORIGINAL ARTICLE: Detection of in-vitro Activity of Linezolid in Methicillin Resistant Staphylococcus aureus Infections by E-test
by: Lakshmi S. Kakhandki, et al.
Published: (2012-07-01)

Molecular characteristics and risk factors associated with linezolid-resistant Enterococcus faecalis infection in Southwest China
by: Jiaqi Zou, et al.
Published: (2020-09-01)

Revisiting methicillin-resistant Staphylococcus aureus infections
by: Abdelkarim Waness
Published: (2010-01-01)

Radezolid Is More Effective Than Linezolid Against Planktonic Cells and Inhibits Enterococcus faecalis Biofilm Formation
by: Jinxin Zheng, et al.
Published: (2020-02-01)